Participant Experience

Print

Ranked among the highest-rated Harvard Medical School CME courses, past participants consistently report that this program has inspired and improved their clinical practice and outcomes. Here are a number of comments from recent attendees:

Dear Dr. Basgoz,

I write to say "Brava!" . ...This year's course satisfied my three criteria for a substantive educational experience:

  1. ​New and meaningful information on topics that I don't know much about (e.g., transplant ID)
  2. New and meaningful information on topics in which I have a good deal of expertise (e.g., bone and joint infections, tick-borne illness)
  3. Not falling asleep in any of the lectures!

Once again, kudos on a job well done.


“I am now better able to diagnose, understand, and manage a number of complex and difficult ID problems, especially the treatment of non-tuberculous bacterial infections; infections in pregnancy (especially managing HIV positive couples who wish to have children); bone and joint infections; hospital infections…the list goes on.”
 

“My patients are seeing better outcomes because of the information presented at this course concerning tick/vector-borne diseases.”
 

“I have quite a list of practice changes, from upgrading immunization practices, to better use of lab testing, to more sensible antibiotic use.”
 

“I am much more confident in treating Hep C patients.”
 

“The quality of the lectures at ID in Adults is far superior to any other courses I have been to.”
 

“This course has led to the expanding the evaluation of my Lyme patients to assess for babesia, anaplasmosis, and erlichia.”
 

“I have optimized my treatment of fungal infections and my approach to C. difficile, and have a much improved understanding of Staph aureus pathogenesis.”
 

“I can better treat MDRO and have improved the care of immunocompromised patients.”
 

“All the experts showed great respect for their patients as well as their colleagues.”
 

“I have set up rapid access on my computer for quick referral to some of the website resources provided in this course.”
 

“Thanks to this course, I have improved STD treatment and screening, treatment for Lyme disease, and assessing eye infections.”
 

“The NEJM ClinicoPathologic Conference session was a superb educational instrument.”
 

“The practice-based learning and improvement offered at this course is exceptional. “
 

“I have changed my decisions as to which patients to prophylax in those taking biologic agents, and have updated my approach to infection control, penicillin testing, and C. diff. management.”
 

“I have updated my own and my clinic’s approach to TB, HIV, and UTIs.”
 

“The discussion of rare cases helped me a lot as I work in a tertiary hospital where we see many rare cases.”
 

“The content of the course was very practical for a clinician in day-to-day practice.”
 

“The availability of all the faculty for questions and discussions on complex ID issues and their willingness to spend time discussing and clarifying questions was outstanding.”
 

“This course not only helped me polish my clinical approach to ID consult, it was the best educational event in my ID career in the last ten years. Very motivating!!”
 

“The sheer breadth of coverage and the quality of presenters and presentations is unparalleled.”
 

“I work in transplant (and am a relatively new PA). The course provided a thorough review of ID, reminded me to broaden differential, and gave me the most up-to-date antibiotic best practices.”
 

“As a primary care physician, the conference was pivotal in how I now approach and diagnose my patient population.”
 

Of Special Interest to ID PHYSICIANS, NPs/PAs and Pharmacists:

“My approach to HIV management, vaccines, ENT and eye care, Herpes viruses, UTIs, and endocarditis have all changed due to this course.”
 

“It was very helpful and eye-opening to get expert opinions and hear what is being done at MGH in areas of controversy and uncertainties in clinical practice—areas not covered by standard guidelines.”
 

“Having attended this course, I was able to achieve improvements in differential diagnosis.”
 

“I see a lot of cellulitis, pneumonia and COPD exacerbation.  I was able to incorporate what was taught in this program to develop more effective protocols for each.”
 

“I found the updates in HIV care to be particularly influential in determining appropriate ART regimens.”
 

“I’ve made important changes in the antibiotic choices I choose to treat certain infections and also achieved improvements in antibiotic stewardship.”
 

“The information in this course regarding high-risk patients is invaluable, from when to start antifungal therapy, employ galactomannan testing, and increase use of HPV and shingles vaccines, to looking for Bartonella in culture-negative endocarditis.”
 

“We were able to improve OPAT in clinical practice.”
 

“I identified areas where we could improve patient management and how we test and select appropriate antimicrobials.”
 

“I got state-of-the-art developments for Hepatitis C and STDs.”
 

“I’ve implemented improved diagnostic approaches, broader differential diagnoses, and expanded immunization and prevention approaches.”
 

“I sent a list of about 50 pearls I gleaned from this conference to my ID partners.”
 

“I have started an antimicrobial stewardship program in the outpatient setting.”
 

“What was the most helpful section of this program? There were actually too many to name, but offhand, the lectures about immunocompromised patients, the vaccine update and the drug review proved to be enormously value to my practice.”
 

“The presentations on bone infections, tropical medicine, TB, and diagnostics were exceptional and very helpful to my practice.”

 

Of Special Interest to HOSPITALISTS, PULMONARY and CRITICAL CARE SPECIALISTS, TRANSPLANTATION SPECIALISTS, and EMERGENCY ROOM CLINICIANS:

“This program has helped me provide better management of patients on biologics and patients who require immunosuppression.”
 

“This information helped us to restructure our approach to the immunocompromised patients in our hospital, including bone marrow transplant recipients and biologic therapy recipients, to ensure adequate vaccination, prophylaxis and early diagnosis and treatment of the possible infections that occur after immunocompromise.”
 

“We changed some key formulary and lab practices at my hospital as well as our pre-immunosuppression exams.”
 

“In my facility we have many solid organ transplants. The sessions that dealt with infectious disease in immunocompromised patients was very timely and extremely helpful.”
 

“I work at the ER, where I was able to immediately apply the new information that was given to me on rabies, HCV, and HIV.”

 

Of Special Interest to INTERNISTS / PRIMARY CARE CLINCIANS:

“After attending, I changed my first line treatment for uncomplicated cystitis. We now carefully consider more rigorous vaccination, different testing methods for STDs, and additional infectious disease screening for homeless and multicultural populations.”
 

“I am now much more knowledgeable about treatment of and patient counseling for zoonoses, including rabies vaccines.”
 

“I gained an awareness of certain issues that as a general internist in a rural area I might have overlooked, specifically in STD and acute HIV, so I now test a bit more than I previously had in certain situations.”
 

“As a general internist, I got important updates regarding a number of the diseases that I see on a regular basis.”